Johnson & Johnson
JNJ (NYSE)
Johnson & Johnson stands out as a diversified healthcare leader with a strong presence across pharmaceuticals, medical devices, and consumer health markets. The company boasts a solid dividend yield of 2.28% and has delivered impressive returns, including a 67.09% increase over the past year. Analysts have a positive outlook, with a median 12-month price target of $260, reflecting strong confidence in its ongoing growth trajectory.
Pros:
- Strong brand recognition
- Consistent dividend payments
Cons:
- Litigation risks
- Market competition
Johnson & Johnson (JNJ) presents a compelling investment opportunity for those seeking exposure to a diversified healthcare leader with a history of strong returns and reliable dividends. Its solid performance and positive analyst outlook may attract both growth-oriented investors and income-focused individuals looking for stability in their portfolios.